Eyebright Medical Technology Beijing Co Ltd
SSE:688050

Watchlist Manager
Eyebright Medical Technology Beijing Co Ltd Logo
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Watchlist
Price: 96.22 CNY -0.55%
Market Cap: 18.2B CNY
Have any thoughts about
Eyebright Medical Technology Beijing Co Ltd?
Write Note

Gross Margin
Eyebright Medical Technology Beijing Co Ltd

72.2%
Current
81%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.2%
=
Gross Profit
774.2m
/
Revenue
1.1B

Gross Margin Across Competitors

Country CN
Market Cap 18.2B CNY
Gross Margin
72%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 38.2B CHF
Gross Margin
55%
Country DK
Market Cap 177.1B DKK
Gross Margin
68%
Country US
Market Cap 16.3B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country US
Market Cap 6.7B USD
Gross Margin
65%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
Country US
Market Cap 5.6B USD
Gross Margin
47%
No Stocks Found

Eyebright Medical Technology Beijing Co Ltd
Glance View

Market Cap
18.2B CNY
Industry
Health Care

Nestled in the bustling heart of Beijing, Eyebright Medical Technology Co., Ltd. stands as a beacon of innovative healthcare solutions in China. Founded with the vision of transforming patient experiences and outcomes, the company has carved a niche for itself in the ophthalmic devices sector. Eyebright's story is one of relentless pursuit of excellence, where cutting-edge technology and medical expertise converge. The company has built its reputation around developing advanced medical instruments and devices tailored specifically for eye care, addressing pressing needs in ophthalmology by enhancing diagnostic and treatment capabilities. Their products, ranging from sophisticated intraocular lenses to state-of-the-art surgical equipment, are designed to not only improve precision in surgeries but also to elevate the overall efficiency and safety of ophthalmic procedures. Eyebright Medical Technology generates its revenue through a balanced ecosystem of product sales and strategic alliances. The company leverages its robust research and development arm to continually introduce new products and update existing ones, ensuring compatibility with the latest medical standards and customer demands. Collaborating with a network of hospitals, clinics, and healthcare providers, Eyebright extends its reach across China and beyond, supplying essential ophthalmic equipment to practitioners dedicated to superior eye care. Furthermore, by maintaining strong partnerships with global optical giants, they benefit from cross-border knowledge and technology exchange, which fuels their growth trajectory. This multifaceted approach not only anchors them firmly in the healthcare landscape but also positions them advantageously in the face of ever-evolving industry challenges.

Intrinsic Value
79.45 CNY
Overvaluation 17%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.2%
=
Gross Profit
774.2m
/
Revenue
1.1B
What is the Gross Margin of Eyebright Medical Technology Beijing Co Ltd?

Based on Eyebright Medical Technology Beijing Co Ltd's most recent financial statements, the company has Gross Margin of 72.2%.